Canada
· Delayed Price · Currency is CAD | Market Cap | 9.09M |
| Revenue (ttm) | 28.81K |
| Net Income (ttm) | -3.11M |
| Shares Out | 454.46M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,090,769 |
| Average Volume | 685,532 |
| Open | 0.0150 |
| Previous Close | 0.0200 |
| Day's Range | 0.0150 - 0.0200 |
| 52-Week Range | 0.0100 - 0.1000 |
| Beta | 3.59 |
| RSI | 38.23 |
| Earnings Date | Jun 27, 2025 |
About Therma Bright
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company’s products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; V... [Read more]
Financial Performance
In 2024, Therma Bright's revenue was 6,015, an increase of 192.56% compared to the previous year's 2,056. Losses were -2.45 million, -34.94% less than in 2023.
Financial StatementsNews
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
Toronto, Ontario--(Newsfile Corp. - May 8, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced di...
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced...
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced...
Therma Bright gets contract for consumer product devices
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts Toronto, Ontario--(Newsfile Corp. - March 13, 2025) - Therma Brig...
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
Announces Shares for Debt Settlements Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment par...
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
National Distributor Eager To Begin Sales & Marketing Of Vascular Compression Therapy Solutions Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (...
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
National Distributor And Its Network Receive Upwards Of 100 Doctor Referrals Per Day For Vascular Compression Therapy Solutions Toronto, Ontario--(Newsfile Corp. - January 13, 2025) - Therma Bright In...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - January 9, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - January 3, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leading-...
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Initiative Includes Milestone-Based Inventory Purchase Commitments During Q1 and Q2, 2025 Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: ...
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London. Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ...
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
Distributors' medical partner networks impressed with Venowave device, speed of Medicare/Medicaid processing and prepare roadmaps to drive sales Toronto, Ontario--(Newsfile Corp. - December 5, 2024) -...
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologi...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leadin...
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
InStatin to secure exclusive worldwide licensing agreement of InVixa's inhaled statin solution to prevent and treat acute lung disease Toronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Br...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range...
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Test Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900 ...
Therma Bright to raise C$6M via LIFE financing and private placement
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no Warrants Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (...
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human Trials. Toronto, Ontario--(Newsfile Corp. - September 23,...
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement
Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leadi...
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
New Advisory Board Member will focus on Venowave sales and business development efforts Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therm...
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Chairman of Therma Bright's Strategic Investment Partner Recognized for Outstanding Research and Discovery in Respiratory Drug Delivery Toronto, Ontario--(Newsfile Corp. - September 4, 2024) - Therma ...
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
Game-Changing Innovation Poised to Transform Stroke and Blood Clot Treatment Therma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and Safety in Transforming Ischemic ...